Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pax6
|
ENSMUSG00000027168.15 | paired box 6 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_105689482_105689673 | Pax6 | 2906 | 0.225010 | 0.77 | 7.1e-12 | Click! |
chr2_105680297_105680557 | Pax6 | 560 | 0.726814 | 0.76 | 2.1e-11 | Click! |
chr2_105689673_105689859 | Pax6 | 2717 | 0.233726 | 0.75 | 2.9e-11 | Click! |
chr2_105690434_105690620 | Pax6 | 1956 | 0.292040 | 0.75 | 6.6e-11 | Click! |
chr2_105680597_105681214 | Pax6 | 807 | 0.587178 | 0.74 | 1.1e-10 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_91412838_91413226 | 54.60 |
Tshr |
thyroid stimulating hormone receptor |
12032 |
0.2 |
chr16_85092305_85093056 | 49.68 |
Gm49227 |
predicted gene, 49227 |
12569 |
0.2 |
chr1_25892463_25892638 | 43.36 |
Gm9884 |
predicted gene 9884 |
61893 |
0.08 |
chr1_66388570_66388940 | 42.61 |
Map2 |
microtubule-associated protein 2 |
1744 |
0.39 |
chr19_16880103_16880286 | 41.90 |
Foxb2 |
forkhead box B2 |
6389 |
0.21 |
chr2_154421078_154421682 | 40.82 |
Snta1 |
syntrophin, acidic 1 |
13281 |
0.16 |
chr3_119947205_119947510 | 40.50 |
Gm18384 |
predicted gene, 18384 |
21374 |
0.24 |
chrX_133575644_133575926 | 39.80 |
Pcdh19 |
protocadherin 19 |
12226 |
0.29 |
chr1_35869466_35870086 | 37.38 |
1110002O04Rik |
RIKEN cDNA 1110002O04 gene |
10069 |
0.21 |
chr4_20317105_20317256 | 36.89 |
Gm11872 |
predicted gene 11872 |
26526 |
0.24 |
chr1_78167977_78168321 | 36.82 |
Pax3 |
paired box 3 |
28689 |
0.2 |
chr4_105475089_105475539 | 36.77 |
Gm12723 |
predicted gene 12723 |
35918 |
0.21 |
chr3_26641406_26641733 | 36.46 |
Spata16 |
spermatogenesis associated 16 |
3919 |
0.29 |
chr5_16024676_16024946 | 34.22 |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
903 |
0.62 |
chr13_78580917_78581111 | 34.10 |
Gm48402 |
predicted gene, 48402 |
57003 |
0.14 |
chr12_69908614_69908818 | 33.68 |
Atl1 |
atlastin GTPase 1 |
984 |
0.44 |
chr18_62863041_62863580 | 33.33 |
Gm50128 |
predicted gene, 50128 |
58791 |
0.11 |
chr10_22591845_22591996 | 31.10 |
Slc2a12 |
solute carrier family 2 (facilitated glucose transporter), member 12 |
53091 |
0.12 |
chr8_32884727_32884989 | 30.86 |
Nrg1 |
neuregulin 1 |
61 |
0.99 |
chr2_50971005_50971315 | 30.81 |
Gm13498 |
predicted gene 13498 |
61476 |
0.15 |
chr13_81629318_81629676 | 29.43 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
3642 |
0.24 |
chr2_83165962_83166116 | 29.20 |
Gm28675 |
predicted gene 28675 |
39823 |
0.2 |
chr9_77502694_77502965 | 28.91 |
Lrrc1 |
leucine rich repeat containing 1 |
29615 |
0.14 |
chr12_5216154_5216371 | 28.62 |
Gm48532 |
predicted gene, 48532 |
19702 |
0.23 |
chr12_58512603_58512786 | 28.45 |
Clec14a |
C-type lectin domain family 14, member a |
243404 |
0.02 |
chr2_51066438_51066648 | 28.37 |
Rnd3 |
Rho family GTPase 3 |
82551 |
0.1 |
chr4_136820408_136820559 | 28.24 |
Ephb2 |
Eph receptor B2 |
15360 |
0.19 |
chr16_52601139_52601295 | 28.19 |
Gm49634 |
predicted gene, 49634 |
19809 |
0.28 |
chr2_52512323_52512474 | 28.10 |
Gm13541 |
predicted gene 13541 |
39571 |
0.14 |
chr11_25356934_25357152 | 28.03 |
4933427E13Rik |
RIKEN cDNA 4933427E13 gene |
27086 |
0.22 |
chr7_76560879_76561212 | 27.74 |
2310001K20Rik |
RIKEN cDNA 2310001K20 gene |
50020 |
0.18 |
chr1_69023473_69023624 | 27.55 |
Gm16076 |
predicted gene 16076 |
83192 |
0.09 |
chr4_32219502_32219702 | 27.12 |
Gm11929 |
predicted gene 11929 |
12454 |
0.18 |
chr2_113828044_113828197 | 27.07 |
Scg5 |
secretogranin V |
642 |
0.73 |
chr5_27048220_27048429 | 26.84 |
Dpp6 |
dipeptidylpeptidase 6 |
875 |
0.69 |
chr5_74999059_74999549 | 26.52 |
Gm42577 |
predicted gene 42577 |
10238 |
0.14 |
chr10_90576386_90576809 | 26.18 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
15 |
0.99 |
chr15_10421430_10421775 | 25.92 |
Dnajc21 |
DnaJ heat shock protein family (Hsp40) member C21 |
28390 |
0.15 |
chr16_85106664_85106911 | 25.88 |
Gm49227 |
predicted gene, 49227 |
26676 |
0.16 |
chr17_55969161_55969943 | 25.59 |
Shd |
src homology 2 domain-containing transforming protein D |
915 |
0.34 |
chr4_57824680_57824927 | 25.59 |
Pakap |
paralemmin A kinase anchor protein |
3753 |
0.25 |
chr5_21272114_21272277 | 25.49 |
Gm43214 |
predicted gene 43214 |
7426 |
0.18 |
chrX_137806852_137807006 | 25.29 |
Il1rapl2 |
interleukin 1 receptor accessory protein-like 2 |
155209 |
0.04 |
chr7_117618964_117619337 | 25.03 |
Xylt1 |
xylosyltransferase 1 |
143658 |
0.05 |
chr10_36729750_36729997 | 24.69 |
Gm22554 |
predicted gene, 22554 |
46058 |
0.19 |
chr15_15976980_15977159 | 24.67 |
Gm29753 |
predicted gene, 29753 |
33638 |
0.22 |
chr18_47170408_47170559 | 24.57 |
Gm25036 |
predicted gene, 25036 |
16110 |
0.16 |
chr7_79531898_79532317 | 23.85 |
Gm35040 |
predicted gene, 35040 |
3936 |
0.11 |
chr18_38014515_38014680 | 23.64 |
Gm30093 |
predicted gene, 30093 |
8932 |
0.11 |
chr1_73850450_73850601 | 23.64 |
Mir6351 |
microRNA 6351 |
5050 |
0.19 |
chr11_84382584_84382752 | 23.59 |
Aatf |
apoptosis antagonizing transcription factor |
66865 |
0.11 |
chr18_46109567_46109759 | 23.52 |
Gm38337 |
predicted gene, 38337 |
3596 |
0.27 |
chr13_73041854_73042050 | 23.33 |
Rpl31-ps2 |
ribosomal protein L31, pseudogene 2 |
191443 |
0.03 |
chr14_103763556_103763746 | 23.33 |
Slain1os |
SLAIN motif family, member 1, opposite strand |
64209 |
0.11 |
chr4_75562472_75562807 | 23.29 |
Gm11259 |
predicted gene 11259 |
181879 |
0.03 |
chr7_122477929_122478146 | 23.29 |
Gm14389 |
predicted gene 14389 |
6383 |
0.17 |
chr7_78071324_78071526 | 23.24 |
Gm44358 |
predicted gene, 44358 |
44785 |
0.18 |
chr14_115616974_115617125 | 23.19 |
Gm18367 |
predicted gene, 18367 |
60527 |
0.16 |
chr12_49381565_49382180 | 23.16 |
Gm34304 |
predicted gene, 34304 |
13 |
0.93 |
chr6_15639488_15639689 | 22.76 |
Gm44039 |
predicted gene, 44039 |
3464 |
0.35 |
chrX_99505971_99506130 | 22.72 |
Pja1 |
praja ring finger ubiquitin ligase 1 |
34777 |
0.17 |
chr2_57378479_57378900 | 22.55 |
Gm13531 |
predicted gene 13531 |
47020 |
0.16 |
chr8_67520373_67520528 | 22.46 |
Nat3 |
N-acetyltransferase 3 |
3404 |
0.2 |
chr12_28460953_28461147 | 22.42 |
Dcdc2c |
doublecortin domain containing 2C |
55664 |
0.11 |
chr2_179094031_179094351 | 22.25 |
Gm14314 |
predicted gene 14314 |
73058 |
0.11 |
chr4_152834006_152834205 | 22.14 |
Gm833 |
predicted gene 833 |
136565 |
0.05 |
chr8_57962785_57962959 | 22.13 |
Galntl6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 |
308 |
0.93 |
chrX_136714947_136715426 | 22.12 |
Tceal1 |
transcription elongation factor A (SII)-like 1 |
7204 |
0.12 |
chr4_71485302_71485664 | 22.09 |
Rps18-ps1 |
ribosomal protein S18, pseudogene 1 |
114287 |
0.07 |
chr4_149220099_149220294 | 22.07 |
Kif1b |
kinesin family member 1B |
3322 |
0.22 |
chr12_98574931_98575152 | 21.88 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
86 |
0.96 |
chr8_125157242_125157440 | 21.87 |
Disc1 |
disrupted in schizophrenia 1 |
69354 |
0.1 |
chr13_71165659_71165842 | 21.85 |
Mir466f-4 |
microRNA 466f-4 |
58661 |
0.15 |
chr2_109626971_109627122 | 21.77 |
Gm20638 |
predicted gene 20638 |
46120 |
0.13 |
chr18_25377822_25377990 | 21.74 |
Gm16558 |
predicted gene 16558 |
13895 |
0.27 |
chr4_75213011_75213603 | 21.66 |
Dmac1 |
distal membrane arm assembly complex 1 |
64998 |
0.1 |
chr2_5381837_5382302 | 21.57 |
Gm13197 |
predicted gene 13197 |
98419 |
0.07 |
chr10_36533818_36533969 | 21.55 |
Hs3st5 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 5 |
26486 |
0.24 |
chr11_93829394_93829739 | 21.50 |
Utp18 |
UTP18 small subunit processome component |
46577 |
0.14 |
chr2_71245376_71245868 | 21.40 |
Dync1i2 |
dynein cytoplasmic 1 intermediate chain 2 |
10823 |
0.2 |
chr17_85393391_85393584 | 21.36 |
Rpl31-ps16 |
ribosomal protein L31, pseudogene 16 |
105146 |
0.07 |
chr15_44381799_44381950 | 21.35 |
Gm25093 |
predicted gene, 25093 |
17789 |
0.14 |
chr12_29698995_29699399 | 21.23 |
C630031E19Rik |
RIKEN cDNA C630031E19 gene |
12752 |
0.29 |
chr9_47900833_47901024 | 21.16 |
Gm47213 |
predicted gene, 47213 |
47233 |
0.14 |
chr5_53708248_53708432 | 21.16 |
Cckar |
cholecystokinin A receptor |
635 |
0.79 |
chr4_141541952_141542136 | 20.86 |
Spen |
spen family transcription repressor |
3447 |
0.16 |
chr2_179787267_179787680 | 20.80 |
Cdh4 |
cadherin 4 |
10310 |
0.27 |
chr14_105851365_105851748 | 20.80 |
Gm48970 |
predicted gene, 48970 |
10945 |
0.21 |
chr2_161265509_161265695 | 20.79 |
Gm5270 |
predicted gene 5270 |
10145 |
0.19 |
chr10_10301258_10301430 | 20.74 |
Gm48324 |
predicted gene, 48324 |
4415 |
0.22 |
chr9_13525510_13525824 | 20.74 |
Gm47089 |
predicted gene, 47089 |
5731 |
0.25 |
chr1_165934961_165935308 | 20.67 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
123 |
0.95 |
chr10_22271501_22271686 | 20.62 |
H60b |
histocompatibility 60b |
1753 |
0.22 |
chr3_50300149_50300300 | 20.58 |
Gm2345 |
predicted gene 2345 |
45369 |
0.16 |
chr11_88447561_88447712 | 20.54 |
Gm11510 |
predicted gene 11510 |
14122 |
0.22 |
chr5_51412279_51412789 | 20.48 |
Gm42614 |
predicted gene 42614 |
71771 |
0.1 |
chr10_22461497_22461758 | 20.47 |
Gm26585 |
predicted gene, 26585 |
8107 |
0.2 |
chr2_101592129_101592615 | 20.39 |
B230118H07Rik |
RIKEN cDNA B230118H07 gene |
7438 |
0.19 |
chr13_48131907_48132058 | 20.37 |
Gm36101 |
predicted gene, 36101 |
100209 |
0.06 |
chr11_34284667_34284818 | 20.32 |
4930403D09Rik |
RIKEN cDNA 4930403D09 gene |
14965 |
0.18 |
chr13_48130894_48131449 | 20.09 |
Gm36101 |
predicted gene, 36101 |
99398 |
0.06 |
chr11_16591408_16591584 | 19.93 |
Gm12663 |
predicted gene 12663 |
44570 |
0.12 |
chr16_38941251_38941603 | 19.82 |
Gm22500 |
predicted gene, 22500 |
14218 |
0.21 |
chr16_29719863_29720466 | 19.69 |
Gm49636 |
predicted gene, 49636 |
34148 |
0.18 |
chr16_21625962_21626113 | 19.63 |
Vps8 |
VPS8 CORVET complex subunit |
1594 |
0.46 |
chr3_109561341_109561658 | 19.53 |
Vav3 |
vav 3 oncogene |
12408 |
0.3 |
chr10_19277550_19277710 | 19.53 |
Gm33056 |
predicted gene, 33056 |
13359 |
0.19 |
chr1_127577170_127577459 | 19.49 |
Tmem163 |
transmembrane protein 163 |
39884 |
0.18 |
chr6_89013133_89013322 | 19.39 |
4933427D06Rik |
RIKEN cDNA 4933427D06 gene |
62544 |
0.09 |
chr9_73867567_73867718 | 19.27 |
Gm37326 |
predicted gene, 37326 |
7464 |
0.26 |
chr12_29957060_29957211 | 19.16 |
Pxdn |
peroxidasin |
19085 |
0.24 |
chr14_79879709_79880028 | 19.09 |
Gm10845 |
predicted gene 10845 |
10692 |
0.16 |
chr17_17396978_17397144 | 19.03 |
Lix1 |
limb and CNS expressed 1 |
5611 |
0.15 |
chr1_119255816_119256016 | 18.92 |
Gm3508 |
predicted gene 3508 |
13163 |
0.21 |
chr13_83737818_83738360 | 18.88 |
Gm33366 |
predicted gene, 33366 |
446 |
0.49 |
chr4_125194460_125194614 | 18.86 |
1700041M05Rik |
RIKEN cDNA 1700041M05 gene |
34060 |
0.15 |
chr8_41055517_41055685 | 18.80 |
Mtus1 |
mitochondrial tumor suppressor 1 |
807 |
0.55 |
chr6_16636181_16636336 | 18.73 |
Gm36503 |
predicted gene, 36503 |
85871 |
0.1 |
chr4_150730280_150730563 | 18.65 |
Gm16079 |
predicted gene 16079 |
51629 |
0.12 |
chr2_28387385_28387853 | 18.55 |
Ppp1r26 |
protein phosphatase 1, regulatory subunit 26 |
59181 |
0.09 |
chr9_28212054_28212205 | 18.49 |
Gm15606 |
predicted gene 15606 |
14189 |
0.28 |
chr2_24408191_24408394 | 18.46 |
Psd4 |
pleckstrin and Sec7 domain containing 4 |
2663 |
0.21 |
chr4_5724465_5724747 | 18.43 |
Fam110b |
family with sequence similarity 110, member B |
294 |
0.93 |
chr16_46617636_46617787 | 18.34 |
Gm17900 |
predicted gene, 17900 |
79876 |
0.11 |
chr14_48524282_48524433 | 18.30 |
Gm49519 |
predicted gene, 49519 |
237 |
0.89 |
chr10_59078024_59078279 | 18.24 |
Sh3rf3 |
SH3 domain containing ring finger 3 |
1883 |
0.42 |
chr17_9726102_9726458 | 18.14 |
Gm34684 |
predicted gene, 34684 |
73 |
0.98 |
chr5_99787450_99787615 | 18.11 |
Gm38413 |
predicted gene, 38413 |
33559 |
0.13 |
chr8_84936253_84936414 | 18.05 |
Mast1 |
microtubule associated serine/threonine kinase 1 |
1011 |
0.26 |
chr2_83759211_83759535 | 17.97 |
Gm13684 |
predicted gene 13684 |
492 |
0.77 |
chr12_25033801_25033952 | 17.81 |
Kidins220 |
kinase D-interacting substrate 220 |
15357 |
0.17 |
chr4_149255354_149255580 | 17.74 |
Kif1b |
kinesin family member 1B |
7488 |
0.18 |
chr15_64446527_64446678 | 17.67 |
Gm30563 |
predicted gene, 30563 |
50223 |
0.15 |
chr15_26308701_26309304 | 17.66 |
Marchf11 |
membrane associated ring-CH-type finger 11 |
46 |
0.99 |
chr9_17500285_17500465 | 17.64 |
Gm2594 |
predicted gene 2594 |
2334 |
0.37 |
chr14_92958191_92958435 | 17.49 |
Gm48963 |
predicted gene, 48963 |
65611 |
0.13 |
chr7_51510693_51511226 | 17.35 |
Ano5 |
anoctamin 5 |
70 |
0.98 |
chr7_45460493_45461322 | 17.33 |
Ftl1 |
ferritin light polypeptide 1 |
1023 |
0.19 |
chr18_71975885_71976151 | 17.30 |
Dcc |
deleted in colorectal carcinoma |
374999 |
0.01 |
chr7_4546262_4546455 | 17.28 |
Syt5 |
synaptotagmin V |
209 |
0.84 |
chr15_90827906_90828107 | 17.23 |
Tcea1-ps1 |
transcription elongation factor A (SII) 1, pseudogene 1 |
54609 |
0.1 |
chr18_58053558_58053715 | 17.20 |
Fbn2 |
fibrillin 2 |
17658 |
0.27 |
chr8_28601791_28601942 | 17.17 |
Gm26795 |
predicted gene, 26795 |
8334 |
0.28 |
chr13_83736071_83736420 | 17.17 |
Gm33366 |
predicted gene, 33366 |
2290 |
0.18 |
chr6_114174430_114174797 | 17.14 |
Gm8132 |
predicted gene 8132 |
5090 |
0.24 |
chr9_69766455_69766606 | 17.13 |
B230323A14Rik |
RIKEN cDNA B230323A14 gene |
5384 |
0.2 |
chr18_13031872_13032061 | 17.11 |
Hrh4 |
histamine receptor H4 |
24929 |
0.18 |
chr14_45388403_45389548 | 17.07 |
Gnpnat1 |
glucosamine-phosphate N-acetyltransferase 1 |
14 |
0.96 |
chr17_72194935_72195301 | 17.06 |
Gm19183 |
predicted gene, 19183 |
61140 |
0.15 |
chr9_37057882_37058033 | 17.04 |
Pknox2 |
Pbx/knotted 1 homeobox 2 |
25322 |
0.13 |
chrX_152973538_152973758 | 17.02 |
Usp51 |
ubiquitin specific protease 51 |
32821 |
0.13 |
chr3_76074398_76074842 | 16.98 |
Fstl5 |
follistatin-like 5 |
61 |
0.98 |
chr13_110280472_110281172 | 16.93 |
Rab3c |
RAB3C, member RAS oncogene family |
79 |
0.98 |
chr4_22478892_22479069 | 16.93 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
9386 |
0.17 |
chr9_83098721_83098917 | 16.91 |
Gm38398 |
predicted gene, 38398 |
595 |
0.67 |
chr5_99274158_99274645 | 16.91 |
Gm35394 |
predicted gene, 35394 |
306 |
0.92 |
chr5_17292672_17292823 | 16.89 |
Gm6673 |
predicted gene 6673 |
64813 |
0.12 |
chr2_105661882_105662074 | 16.84 |
Paupar |
Pax6 upstream antisense RNA |
635 |
0.68 |
chr7_63113779_63113930 | 16.75 |
Gm44741 |
predicted gene 44741 |
22436 |
0.26 |
chr5_23256073_23256224 | 16.74 |
Gm28022 |
predicted gene, 28022 |
23763 |
0.17 |
chr10_56974940_56975091 | 16.72 |
Gm36827 |
predicted gene, 36827 |
7217 |
0.27 |
chr9_121303770_121304136 | 16.70 |
Trak1 |
trafficking protein, kinesin binding 1 |
6124 |
0.15 |
chr11_16257044_16257441 | 16.63 |
Vstm2a |
V-set and transmembrane domain containing 2A |
482 |
0.85 |
chr3_130963122_130963520 | 16.62 |
2010110G14Rik |
RIKEN cDNA 2010110G14 gene |
25984 |
0.12 |
chr1_155233440_155234889 | 16.60 |
BC034090 |
cDNA sequence BC034090 |
1253 |
0.38 |
chr14_4415827_4416278 | 16.60 |
Gm3164 |
predicted gene 3164 |
604 |
0.63 |
chr12_11436450_11436779 | 16.57 |
Vsnl1 |
visinin-like 1 |
1 |
0.97 |
chr4_72159971_72160487 | 16.54 |
Gm11250 |
predicted gene 11250 |
8539 |
0.22 |
chr11_5129010_5129508 | 16.49 |
Emid1 |
EMI domain containing 1 |
17 |
0.97 |
chr1_109982172_109982351 | 16.47 |
Cdh7 |
cadherin 7, type 2 |
170 |
0.98 |
chr4_142267860_142268115 | 16.45 |
Kazn |
kazrin, periplakin interacting protein |
28586 |
0.2 |
chr17_66412197_66412470 | 16.44 |
Gm4705 |
predicted gene 4705 |
1651 |
0.35 |
chr15_43940257_43940713 | 16.43 |
Tmem74 |
transmembrane protein 74 |
70449 |
0.13 |
chrX_96712988_96713192 | 16.42 |
Gpr165 |
G protein-coupled receptor 165 |
351 |
0.93 |
chr2_179537224_179537761 | 16.36 |
Gm14300 |
predicted gene 14300 |
76075 |
0.1 |
chr6_97339209_97339549 | 16.33 |
Frmd4b |
FERM domain containing 4B |
14798 |
0.23 |
chr2_105337474_105337813 | 16.33 |
Rcn1 |
reticulocalbin 1 |
57705 |
0.13 |
chr14_59736746_59737101 | 16.32 |
Gm19716 |
predicted gene, 19716 |
94375 |
0.07 |
chr18_55379560_55379763 | 16.32 |
Gm37828 |
predicted gene, 37828 |
40149 |
0.2 |
chr3_68202202_68202415 | 16.31 |
Gm10292 |
predicted gene 10292 |
130888 |
0.05 |
chr19_24312924_24313102 | 16.30 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
4329 |
0.21 |
chr5_98180681_98181156 | 16.29 |
Prdm8 |
PR domain containing 8 |
60 |
0.97 |
chr4_32359383_32359534 | 16.28 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
57977 |
0.14 |
chr13_28792466_28792753 | 16.25 |
Gm17528 |
predicted gene, 17528 |
34514 |
0.16 |
chr6_104028571_104028775 | 16.20 |
Gm21054 |
predicted gene, 21054 |
64034 |
0.15 |
chr8_53368812_53368963 | 16.18 |
Gm45554 |
predicted gene 45554 |
67213 |
0.13 |
chr7_83201618_83202091 | 16.16 |
5930435M05Rik |
RIKEN cDNA 5930435M05 gene |
268 |
0.92 |
chr5_4812452_4812648 | 16.14 |
Gm43112 |
predicted gene 43112 |
10077 |
0.12 |
chr1_42704519_42704707 | 16.13 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
3439 |
0.17 |
chr2_117928131_117928282 | 16.05 |
4930412B13Rik |
RIKEN cDNA 4930412B13 gene |
106278 |
0.06 |
chr15_5335996_5336147 | 16.05 |
Gm2150 |
predicted gene 2150 |
20210 |
0.17 |
chr4_22486775_22486926 | 15.94 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
1516 |
0.35 |
chr7_136491174_136491643 | 15.94 |
Gm36849 |
predicted gene, 36849 |
138044 |
0.04 |
chr12_52435871_52436022 | 15.88 |
Gm47431 |
predicted gene, 47431 |
12179 |
0.22 |
chr2_132444544_132444715 | 15.88 |
4921508D12Rik |
RIKEN cDNA 4921508D12 gene |
19888 |
0.16 |
chr2_143614973_143615124 | 15.88 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
67211 |
0.11 |
chr1_159593926_159594077 | 15.88 |
Gm37731 |
predicted gene, 37731 |
1147 |
0.54 |
chr5_24550970_24551337 | 15.87 |
Iqca1l |
IQ motif containing with AAA domain 1 like |
1480 |
0.23 |
chr7_89766840_89767059 | 15.86 |
Gm15744 |
predicted gene 15744 |
5274 |
0.21 |
chr4_42182317_42182468 | 15.80 |
1700045I11Rik |
RIKEN cDNA 1700045I11 gene |
11547 |
0.08 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.5 | 37.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
7.4 | 22.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
5.8 | 17.3 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
5.3 | 31.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
4.6 | 13.9 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
4.5 | 13.6 | GO:1900368 | regulation of RNA interference(GO:1900368) |
4.2 | 8.4 | GO:0060594 | mammary gland specification(GO:0060594) |
4.2 | 20.9 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
4.2 | 12.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
4.1 | 16.4 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
4.0 | 11.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
3.9 | 46.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
3.9 | 11.6 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
3.8 | 11.5 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
3.8 | 11.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
3.6 | 10.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
3.3 | 9.8 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.3 | 9.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
3.2 | 9.7 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
3.2 | 6.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
3.1 | 9.3 | GO:0071873 | response to norepinephrine(GO:0071873) |
3.0 | 11.8 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
2.9 | 8.6 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.7 | 8.2 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.6 | 7.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
2.6 | 5.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.6 | 7.7 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
2.6 | 10.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
2.5 | 7.5 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
2.5 | 15.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
2.5 | 22.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
2.5 | 7.4 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
2.4 | 23.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
2.3 | 7.0 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
2.3 | 9.3 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
2.3 | 9.0 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.2 | 15.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
2.2 | 6.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.1 | 4.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.1 | 8.5 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
2.1 | 6.3 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
2.1 | 8.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
2.0 | 8.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
2.0 | 10.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.0 | 12.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
2.0 | 29.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
2.0 | 5.9 | GO:0061511 | centriole elongation(GO:0061511) |
2.0 | 3.9 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.9 | 5.8 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.9 | 11.5 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.8 | 7.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.8 | 12.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.8 | 5.3 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.8 | 5.3 | GO:0072017 | distal tubule development(GO:0072017) |
1.7 | 22.2 | GO:0031643 | positive regulation of myelination(GO:0031643) |
1.7 | 6.7 | GO:0007412 | axon target recognition(GO:0007412) |
1.7 | 10.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
1.7 | 3.3 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
1.7 | 5.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.6 | 3.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.6 | 4.8 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
1.6 | 8.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.6 | 3.2 | GO:0042160 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
1.6 | 7.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.5 | 4.5 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.5 | 4.5 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.5 | 4.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.4 | 4.3 | GO:0007525 | somatic muscle development(GO:0007525) |
1.4 | 7.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.4 | 4.2 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.4 | 6.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.4 | 20.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.4 | 5.5 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
1.4 | 9.6 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.3 | 4.0 | GO:0061743 | motor learning(GO:0061743) |
1.3 | 8.0 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
1.3 | 5.4 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
1.3 | 4.0 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.3 | 10.6 | GO:0071625 | vocalization behavior(GO:0071625) |
1.3 | 14.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.3 | 5.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.3 | 3.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.3 | 10.2 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
1.3 | 3.8 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.2 | 1.2 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
1.2 | 11.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.2 | 6.2 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
1.2 | 2.5 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.2 | 3.7 | GO:0051665 | membrane raft localization(GO:0051665) |
1.2 | 3.7 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.2 | 1.2 | GO:0060066 | oviduct development(GO:0060066) |
1.2 | 3.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.2 | 7.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
1.2 | 3.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.2 | 11.9 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
1.2 | 1.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.2 | 3.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.2 | 3.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.2 | 12.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
1.1 | 8.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.1 | 9.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.1 | 5.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.1 | 19.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.1 | 2.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.1 | 16.7 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
1.1 | 4.4 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.1 | 3.3 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
1.1 | 2.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.1 | 4.4 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
1.1 | 7.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.1 | 4.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
1.1 | 1.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.1 | 1.1 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
1.1 | 2.1 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
1.0 | 26.9 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
1.0 | 3.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.0 | 4.1 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
1.0 | 7.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
1.0 | 3.0 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
1.0 | 17.9 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
1.0 | 2.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.0 | 2.9 | GO:0060437 | lung growth(GO:0060437) |
1.0 | 2.9 | GO:0032252 | secretory granule localization(GO:0032252) |
1.0 | 4.8 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.0 | 1.0 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.0 | 1.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.0 | 1.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.0 | 3.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.9 | 9.5 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.9 | 2.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.9 | 3.8 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.9 | 2.8 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.9 | 0.9 | GO:0060174 | limb bud formation(GO:0060174) |
0.9 | 7.5 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.9 | 2.7 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.9 | 37.8 | GO:0008542 | visual learning(GO:0008542) |
0.9 | 15.2 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.9 | 20.6 | GO:0001964 | startle response(GO:0001964) |
0.9 | 5.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.9 | 2.7 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.9 | 0.9 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.9 | 0.9 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.9 | 3.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.9 | 4.3 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.9 | 3.4 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.9 | 1.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.8 | 2.5 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.8 | 0.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.8 | 0.8 | GO:0060074 | synapse maturation(GO:0060074) |
0.8 | 6.6 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.8 | 7.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.8 | 12.3 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.8 | 0.8 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.8 | 1.6 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.8 | 2.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.8 | 2.4 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.8 | 2.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.8 | 5.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.8 | 2.4 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.8 | 2.4 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.8 | 1.6 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.8 | 4.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.8 | 2.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.8 | 5.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.8 | 3.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.8 | 3.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.8 | 2.3 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.8 | 2.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.8 | 3.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.8 | 8.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.8 | 4.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.7 | 2.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.7 | 1.5 | GO:1903935 | response to sodium arsenite(GO:1903935) |
0.7 | 0.7 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.7 | 2.2 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.7 | 2.2 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.7 | 0.7 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.7 | 63.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.7 | 2.2 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.7 | 3.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.7 | 1.4 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.7 | 1.4 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.7 | 2.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.7 | 4.8 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.7 | 2.8 | GO:0061724 | lipophagy(GO:0061724) |
0.7 | 2.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.7 | 2.7 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.7 | 1.4 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.7 | 2.0 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.7 | 4.7 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.7 | 8.8 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.7 | 3.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.7 | 16.8 | GO:0010107 | potassium ion import(GO:0010107) |
0.7 | 2.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.7 | 3.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.7 | 12.0 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.7 | 4.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.7 | 0.7 | GO:0060435 | bronchiole development(GO:0060435) |
0.7 | 1.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 5.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.6 | 5.8 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.6 | 3.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.6 | 3.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.6 | 1.9 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.6 | 1.9 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.6 | 1.9 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.6 | 9.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.6 | 2.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.6 | 1.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 1.9 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.6 | 6.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.6 | 6.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.6 | 1.2 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.6 | 6.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.6 | 2.5 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.6 | 2.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.6 | 3.7 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.6 | 3.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.6 | 2.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.6 | 1.8 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.6 | 2.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.6 | 1.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.6 | 0.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.6 | 11.3 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.6 | 1.8 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.6 | 5.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.6 | 3.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.6 | 2.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.6 | 2.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.6 | 1.2 | GO:0015755 | fructose transport(GO:0015755) |
0.6 | 1.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.6 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.6 | 1.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 1.7 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.6 | 2.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.6 | 1.1 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.6 | 2.8 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.6 | 1.1 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.6 | 6.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.6 | 3.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.6 | 1.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.6 | 2.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.6 | 3.9 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.5 | 0.5 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.5 | 6.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.5 | 6.0 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.5 | 1.1 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.5 | 0.5 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
0.5 | 1.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.5 | 0.5 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.5 | 3.7 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.5 | 3.7 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.5 | 3.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 1.6 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.5 | 1.0 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.5 | 1.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.5 | 2.6 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.5 | 0.5 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.5 | 0.5 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.5 | 1.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.5 | 11.6 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.5 | 2.0 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.5 | 2.0 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.5 | 0.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.5 | 2.5 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.5 | 2.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 2.0 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.5 | 0.5 | GO:0021764 | amygdala development(GO:0021764) |
0.5 | 1.0 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.5 | 1.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 3.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 1.4 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.5 | 1.0 | GO:0071436 | sodium ion export from cell(GO:0036376) sodium ion export(GO:0071436) regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.5 | 2.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.5 | 1.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.5 | 1.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.5 | 4.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 1.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.5 | 0.5 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.5 | 3.7 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.5 | 1.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.5 | 1.4 | GO:0042938 | dipeptide transport(GO:0042938) |
0.5 | 2.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 0.9 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 1.3 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 1.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 1.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.4 | 8.8 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.4 | 1.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.4 | 1.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.4 | 3.0 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.4 | 1.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.4 | 1.7 | GO:0015867 | ATP transport(GO:0015867) |
0.4 | 1.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.4 | 1.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.4 | 0.9 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.4 | 2.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.4 | 0.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.4 | 0.9 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.4 | 4.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.4 | 9.0 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.4 | 3.8 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.4 | 0.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 1.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.4 | 1.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.4 | 0.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.4 | 3.3 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.4 | 0.4 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.4 | 2.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.4 | 1.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.4 | 22.7 | GO:0007612 | learning(GO:0007612) |
0.4 | 0.8 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.4 | 2.4 | GO:0021854 | hypothalamus development(GO:0021854) |
0.4 | 3.9 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.4 | 0.4 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.4 | 1.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 0.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.4 | 0.8 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.4 | 0.8 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.4 | 1.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.4 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 2.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 0.8 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.4 | 0.8 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.4 | 1.9 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.4 | 0.4 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.4 | 6.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.4 | 0.4 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.4 | 1.9 | GO:0042637 | catagen(GO:0042637) |
0.4 | 1.8 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.4 | 0.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.4 | 2.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.4 | 1.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.4 | 2.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.4 | 2.6 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 0.4 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.4 | 1.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.4 | 0.7 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.4 | 0.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.4 | 1.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.4 | 6.0 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.3 | 1.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 5.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 1.0 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.3 | 1.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.3 | 1.0 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.3 | 1.7 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.3 | 1.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 1.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 6.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.3 | 8.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.3 | 1.3 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 1.7 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 0.7 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.3 | 0.3 | GO:0045472 | response to ether(GO:0045472) |
0.3 | 0.7 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.3 | 3.0 | GO:0034389 | lipid particle organization(GO:0034389) |
0.3 | 1.3 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.3 | 3.9 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.3 | 5.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 3.9 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.3 | 1.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 8.7 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.3 | 1.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 8.0 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.3 | 2.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 0.6 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.3 | 1.6 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.3 | 1.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 1.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 1.6 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.3 | 2.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 0.3 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.3 | 0.9 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 0.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.3 | 1.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.3 | 0.6 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.3 | 0.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 1.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.3 | 0.6 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 4.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.3 | 0.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 0.3 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.3 | 0.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 1.8 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.3 | 0.6 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 2.7 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.3 | 0.6 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.3 | 1.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.3 | 1.5 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.3 | 2.0 | GO:0007616 | long-term memory(GO:0007616) |
0.3 | 2.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.3 | 0.3 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.3 | 3.4 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.3 | 0.3 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.3 | 4.3 | GO:0097576 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.3 | 0.9 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 1.7 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.3 | 2.3 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.3 | 0.6 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.3 | 0.3 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.3 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.3 | 0.3 | GO:0072044 | collecting duct development(GO:0072044) |
0.3 | 1.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.3 | 0.3 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.3 | 2.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.6 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.3 | 1.7 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.3 | 0.3 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.3 | 3.6 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.3 | 0.3 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.3 | 0.6 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.3 | 7.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.3 | 1.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 1.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 1.1 | GO:0036492 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.3 | 1.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 2.5 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.3 | 0.5 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.3 | 0.3 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.3 | 1.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 1.3 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.3 | 2.4 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.3 | 0.5 | GO:0001840 | neural plate development(GO:0001840) |
0.3 | 0.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.3 | 2.1 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.3 | 1.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.3 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 1.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 0.5 | GO:0014842 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.3 | 0.5 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.3 | 1.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 0.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 1.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 0.8 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 1.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 0.8 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.3 | 0.8 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.3 | 0.5 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.3 | 0.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 0.5 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.3 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.3 | 1.3 | GO:0015816 | glycine transport(GO:0015816) |
0.3 | 0.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 1.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 3.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 1.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 0.5 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.2 | 6.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 0.5 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.2 | 1.0 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.2 | 0.7 | GO:0014047 | glutamate secretion(GO:0014047) |
0.2 | 0.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.2 | 3.6 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 1.2 | GO:0032196 | transposition(GO:0032196) |
0.2 | 8.7 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
0.2 | 0.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 0.2 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.2 | 0.7 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 0.5 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 1.1 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.2 | 0.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 2.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 8.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 1.6 | GO:0007135 | meiosis II(GO:0007135) |
0.2 | 0.9 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 3.7 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.2 | 2.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 0.4 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.2 | 0.7 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 0.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 0.6 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.2 | 0.4 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.2 | 0.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 0.2 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 1.1 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.6 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.2 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.2 | 0.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.2 | 1.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.4 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.2 | 0.6 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 1.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.2 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.2 | 1.4 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.2 | 0.8 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 0.4 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.2 | 17.3 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.2 | 1.0 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 0.2 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.2 | 0.4 | GO:0048619 | hindgut morphogenesis(GO:0007442) embryonic hindgut morphogenesis(GO:0048619) |
0.2 | 1.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 1.0 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.2 | 1.0 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.2 | 1.6 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.2 | 1.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 0.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 1.6 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.2 | 0.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.4 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.6 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
0.2 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 1.0 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.2 | 1.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 1.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 1.0 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.6 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 1.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.2 | GO:1902990 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.2 | 0.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.2 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.2 | 3.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.2 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.5 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.2 | 0.4 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.2 | 0.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.5 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.9 | GO:0015879 | carnitine transport(GO:0015879) |
0.2 | 2.5 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.2 | 0.9 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.2 | 2.7 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.2 | 0.9 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 2.3 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.2 | 0.2 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.2 | 0.7 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.2 | 0.3 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 10.0 | GO:0006821 | chloride transport(GO:0006821) |
0.2 | 0.3 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 0.7 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.8 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 8.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 1.0 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.2 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 0.2 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.2 | 10.1 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.2 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 1.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 1.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 0.6 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 1.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 0.2 | GO:0048557 | embryonic digestive tract morphogenesis(GO:0048557) |
0.2 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 0.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 1.2 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.2 | 0.9 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.2 | 0.6 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 1.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 3.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.5 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.2 | 1.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.2 | 0.3 | GO:0072505 | divalent inorganic anion homeostasis(GO:0072505) |
0.2 | 1.4 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.3 | GO:0003163 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.1 | 0.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.1 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 2.2 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.1 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.4 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.1 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.3 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 2.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.1 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 1.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.3 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 4.9 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 1.8 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.4 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.4 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.1 | 0.3 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 1.4 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 3.0 | GO:0048278 | vesicle docking(GO:0048278) |
0.1 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 1.0 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.1 | 0.3 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.6 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.6 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.4 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.4 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 3.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.7 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.1 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.1 | 1.0 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.6 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.4 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.4 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.7 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.2 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 1.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.2 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.1 | 1.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.4 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.4 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.1 | 2.9 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 0.2 | GO:0050918 | positive chemotaxis(GO:0050918) |
0.1 | 1.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 2.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 1.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.1 | 0.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.6 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.1 | 0.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 2.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 1.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.4 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 0.1 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 1.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.2 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.1 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 1.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 1.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 1.2 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.2 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 0.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 1.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.4 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 1.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 0.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.7 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.1 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.2 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 0.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 2.3 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 2.0 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.8 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 1.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 1.6 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.1 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.1 | 0.1 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.1 | 0.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.1 | GO:1900200 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
0.1 | 1.2 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.1 | 0.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.1 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.1 | GO:0061217 | regulation of mesonephros development(GO:0061217) |
0.1 | 0.2 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.4 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.1 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.1 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.1 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 5.6 | GO:0071804 | cellular potassium ion transport(GO:0071804) |
0.1 | 0.2 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 0.3 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.1 | 0.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.1 | 0.2 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 0.1 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.1 | 0.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.7 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.1 | 1.6 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 1.3 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.1 | 0.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.6 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.1 | GO:0001820 | serotonin secretion(GO:0001820) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 1.0 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 0.3 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.1 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.6 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.1 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.1 | 0.1 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 0.2 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.6 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.3 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.1 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 2.5 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.4 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 0.3 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.1 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.7 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.4 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.1 | GO:0006971 | hypotonic response(GO:0006971) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 2.2 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.3 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.1 | 0.5 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.1 | GO:0033206 | parallel actin filament bundle assembly(GO:0030046) meiotic cytokinesis(GO:0033206) polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 0.5 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.1 | 0.1 | GO:0001975 | response to amphetamine(GO:0001975) response to amine(GO:0014075) |
0.1 | 1.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 0.3 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.1 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.1 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.1 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) |
0.1 | 0.7 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.5 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.1 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 1.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.1 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.1 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.1 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.3 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.1 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.1 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.1 | 0.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.4 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.1 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.1 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 0.1 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.1 | GO:0002034 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 3.7 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.0 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.0 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.4 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.3 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.0 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.0 | 0.0 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 1.0 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.0 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.0 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.1 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.1 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.0 | 0.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.0 | GO:1903909 | regulation of receptor clustering(GO:1903909) |
0.0 | 0.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.2 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.0 | 0.0 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.7 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.0 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.2 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.7 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.0 | 0.1 | GO:0009712 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.0 | 0.4 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.0 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.0 | 0.0 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.2 | GO:0071242 | response to ammonium ion(GO:0060359) cellular response to ammonium ion(GO:0071242) |
0.0 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.2 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.0 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.2 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.0 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.4 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.1 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.0 | 0.2 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.1 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.0 | 0.0 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.0 | 0.2 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.0 | GO:0086009 | membrane repolarization(GO:0086009) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.3 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
0.0 | 0.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0036507 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.0 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.0 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.0 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.0 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.0 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.0 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.0 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.0 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.0 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.0 | 0.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.1 | GO:0042402 | amine catabolic process(GO:0009310) cellular biogenic amine catabolic process(GO:0042402) |
0.0 | 0.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.0 | 0.0 | GO:0002423 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.8 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) |
0.0 | 0.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.0 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.0 | 0.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.0 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.0 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.0 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
0.0 | 0.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.0 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.0 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.0 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.0 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.0 | 0.0 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.0 | 0.0 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.1 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.0 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.0 | 0.0 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.0 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.0 | 0.1 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.0 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.0 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.1 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.2 | 27.5 | GO:1990812 | growth cone filopodium(GO:1990812) |
5.6 | 16.9 | GO:0005606 | laminin-1 complex(GO:0005606) |
3.6 | 21.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.2 | 6.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.9 | 9.7 | GO:0071547 | piP-body(GO:0071547) |
1.9 | 35.2 | GO:0030673 | axolemma(GO:0030673) |
1.7 | 7.0 | GO:1990696 | USH2 complex(GO:1990696) |
1.7 | 6.9 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.7 | 8.5 | GO:0097433 | dense body(GO:0097433) |
1.5 | 6.1 | GO:0044308 | axonal spine(GO:0044308) |
1.4 | 11.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.3 | 10.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.2 | 6.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.2 | 3.5 | GO:0044393 | microspike(GO:0044393) |
1.1 | 13.6 | GO:0043194 | axon initial segment(GO:0043194) |
1.1 | 20.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.1 | 8.6 | GO:0043083 | synaptic cleft(GO:0043083) |
1.1 | 6.4 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.0 | 3.0 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.0 | 2.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.0 | 4.0 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.0 | 9.9 | GO:0060091 | kinocilium(GO:0060091) |
1.0 | 14.5 | GO:0031045 | dense core granule(GO:0031045) |
0.9 | 9.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.9 | 2.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.9 | 6.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.8 | 17.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.8 | 2.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.8 | 8.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.8 | 5.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.8 | 10.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.8 | 2.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.7 | 5.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.7 | 2.2 | GO:0043293 | apoptosome(GO:0043293) |
0.7 | 19.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.7 | 26.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 38.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.7 | 27.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.6 | 3.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.6 | 24.3 | GO:0030315 | T-tubule(GO:0030315) |
0.6 | 11.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.6 | 1.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.6 | 4.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.6 | 1.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 3.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.6 | 2.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.6 | 3.4 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.6 | 6.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.6 | 7.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.6 | 2.2 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.6 | 6.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 1.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.6 | 10.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.5 | 2.7 | GO:0001940 | male pronucleus(GO:0001940) |
0.5 | 1.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.5 | 42.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.5 | 1.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 2.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.5 | 2.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.5 | 8.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.5 | 2.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.5 | 1.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 1.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.5 | 4.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.5 | 1.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.5 | 1.5 | GO:0072534 | perineuronal net(GO:0072534) |
0.5 | 7.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 1.9 | GO:0044327 | dendritic spine head(GO:0044327) |
0.5 | 4.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 1.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.5 | 67.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 39.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.5 | 20.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.5 | 1.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.5 | 8.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.4 | 3.5 | GO:0043196 | varicosity(GO:0043196) |
0.4 | 2.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 1.6 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 0.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 1.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 0.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 4.3 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 0.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.4 | 0.8 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 1.1 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 1.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 2.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 1.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 1.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 0.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 2.3 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 5.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 1.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 0.9 | GO:0044299 | C-fiber(GO:0044299) |
0.3 | 0.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 1.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 7.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 17.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 18.2 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 0.8 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 1.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 2.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 1.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 1.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 2.9 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 17.4 | GO:0005814 | centriole(GO:0005814) |
0.2 | 5.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 1.9 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 0.5 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 2.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 2.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 3.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 1.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 0.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 5.9 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.8 | GO:0035363 | histone locus body(GO:0035363) |
0.2 | 1.4 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 8.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 0.7 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 0.5 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.9 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 0.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 1.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.5 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 0.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 11.9 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 1.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 1.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 0.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 1.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 1.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 19.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 2.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.7 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 1.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 1.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 21.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.5 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.5 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 2.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.4 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 3.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.7 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 3.8 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 3.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.9 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.6 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 1.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 72.3 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 3.2 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.6 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 3.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.8 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.7 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 3.7 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.5 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 1.1 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.4 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 4.0 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.6 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.0 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 1.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 6.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.6 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.0 | 0.3 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.0 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0036379 | myofilament(GO:0036379) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.2 | 30.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
6.8 | 20.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
6.4 | 19.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
4.9 | 14.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
4.6 | 13.9 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
4.2 | 12.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
4.0 | 12.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
3.9 | 11.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.7 | 14.9 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
3.6 | 10.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
3.1 | 12.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
3.0 | 9.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.9 | 11.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.9 | 17.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
2.6 | 7.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
2.6 | 10.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.5 | 7.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.3 | 16.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
2.3 | 2.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
2.3 | 9.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
2.3 | 11.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.0 | 5.9 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.9 | 5.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.8 | 7.4 | GO:0009374 | biotin binding(GO:0009374) |
1.8 | 16.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.7 | 10.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.7 | 19.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.7 | 22.2 | GO:0048156 | tau protein binding(GO:0048156) |
1.7 | 10.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.7 | 19.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.6 | 6.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.6 | 24.1 | GO:0030955 | potassium ion binding(GO:0030955) |
1.6 | 25.3 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
1.6 | 4.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.5 | 9.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.5 | 29.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.4 | 4.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.4 | 10.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.3 | 5.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.3 | 29.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.3 | 14.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.3 | 8.9 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.2 | 4.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.2 | 1.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.2 | 3.7 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.2 | 3.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.2 | 6.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.1 | 14.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.1 | 7.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.1 | 5.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.1 | 5.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.0 | 13.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
1.0 | 8.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.0 | 3.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.0 | 17.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.0 | 4.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
1.0 | 14.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
1.0 | 3.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.0 | 2.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.0 | 2.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.0 | 7.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.9 | 0.9 | GO:0051378 | serotonin binding(GO:0051378) |
0.9 | 4.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.9 | 11.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.9 | 2.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.9 | 5.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.9 | 23.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.9 | 2.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.9 | 5.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.9 | 9.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.9 | 12.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.8 | 11.0 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.8 | 3.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.8 | 5.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.8 | 3.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.8 | 2.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.8 | 2.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.8 | 3.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.8 | 5.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.8 | 14.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.8 | 6.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.8 | 4.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.8 | 3.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.8 | 14.0 | GO:0005112 | Notch binding(GO:0005112) |
0.8 | 3.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.7 | 10.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.7 | 5.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.7 | 2.1 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.7 | 2.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.7 | 2.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.7 | 2.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.7 | 15.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.7 | 2.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.7 | 3.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.6 | 7.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 1.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.6 | 8.8 | GO:0070402 | NADPH binding(GO:0070402) |
0.6 | 3.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.6 | 6.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.6 | 13.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.6 | 1.8 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.6 | 1.8 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.6 | 1.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.6 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 4.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.6 | 1.7 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.6 | 6.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.6 | 2.8 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.6 | 1.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 19.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 1.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 2.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.5 | 6.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.5 | 5.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.5 | 8.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.5 | 4.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 2.0 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.5 | 1.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.5 | 7.0 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.5 | 8.0 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.5 | 3.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 1.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.5 | 1.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.5 | 2.9 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.5 | 1.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.5 | 1.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.5 | 1.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 2.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 24.9 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.5 | 0.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.4 | 11.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 8.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 1.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 13.4 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 2.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 16.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.4 | 1.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.4 | 1.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.4 | 4.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 13.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.4 | 0.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 1.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 1.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 0.8 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.4 | 2.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.4 | 10.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 3.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.4 | 1.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.4 | 1.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.4 | 1.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 4.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 1.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 1.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 4.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 1.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 0.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 3.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 1.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.3 | 3.8 | GO:0019914 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.3 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 3.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 4.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 7.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.3 | 3.7 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 4.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.3 | 2.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.3 | 8.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 3.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 1.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 8.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 1.0 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 1.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 12.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 1.9 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 1.0 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 0.6 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 0.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 1.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 8.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 5.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 2.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 1.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 1.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 1.5 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.3 | 3.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 0.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 1.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 3.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.3 | 0.6 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.3 | 1.2 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.3 | 8.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.3 | 3.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 0.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 1.9 | GO:0042300 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.3 | 0.3 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 0.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 3.8 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.3 | 0.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 1.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 1.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 1.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 3.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 15.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.3 | 1.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 3.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 0.3 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 0.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 9.4 | GO:0018721 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.3 | 1.8 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 0.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.2 | 2.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.5 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 1.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 1.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.2 | 2.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 1.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.7 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 1.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 1.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 6.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 0.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 2.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 1.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 1.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 1.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.2 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.2 | 3.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 3.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 1.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 1.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.4 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 2.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 0.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 0.6 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 1.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 0.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 1.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.7 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 3.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 79.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 1.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.7 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 0.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 2.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 0.7 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.2 | 0.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 0.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 1.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 1.0 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.2 | 4.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 0.5 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 0.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 1.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.8 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 1.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 0.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 0.9 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 0.6 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 3.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.9 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 3.7 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 1.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 2.3 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 1.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.5 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 1.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.9 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 2.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 3.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 4.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 1.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 1.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 2.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 5.7 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 6.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 3.8 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.1 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 1.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.3 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.4 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 0.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.9 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 1.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 4.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 1.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 2.5 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 1.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.1 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.8 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 1.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.3 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.3 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.1 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 2.9 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 1.9 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 2.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 1.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.4 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.3 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.6 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 5.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 1.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 1.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 2.5 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.1 | GO:0032405 | guanine/thymine mispair binding(GO:0032137) MutLalpha complex binding(GO:0032405) |
0.1 | 0.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.8 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.3 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.6 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.4 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 0.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.8 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 1.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.2 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.1 | GO:0034824 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.2 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 6.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.0 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.6 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 0.1 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.0 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.0 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.4 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.0 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.8 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.0 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.0 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.7 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.0 | 0.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 36.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.8 | 3.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.5 | 41.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.5 | 16.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.0 | 7.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.9 | 1.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.9 | 8.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.8 | 17.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.7 | 6.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.6 | 18.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 21.7 | PID BMP PATHWAY | BMP receptor signaling |
0.5 | 29.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.4 | 26.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.4 | 8.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.4 | 8.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.4 | 16.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 8.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 3.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 24.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.4 | 6.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 1.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 6.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 47.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 6.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.3 | 2.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 2.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 7.1 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 1.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 0.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 4.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 1.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 1.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 4.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 1.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 3.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 4.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 13.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 1.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 2.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 1.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 5.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 27.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
2.2 | 49.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.0 | 21.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.8 | 1.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.7 | 3.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.4 | 12.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.3 | 13.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.3 | 1.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.2 | 6.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.2 | 17.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
1.1 | 12.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.0 | 2.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.9 | 16.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.9 | 0.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.9 | 7.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.9 | 12.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.9 | 11.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.8 | 13.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.8 | 2.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.8 | 28.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.8 | 5.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.8 | 3.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.7 | 2.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.7 | 7.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 13.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.7 | 8.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.6 | 1.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.6 | 8.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.6 | 6.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.6 | 23.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 4.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.5 | 7.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.5 | 5.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 11.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.5 | 2.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.5 | 5.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.5 | 2.4 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.4 | 6.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 9.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 10.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.4 | 4.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 8.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 7.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 10.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.4 | 4.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 4.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.4 | 1.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.4 | 11.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 2.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 7.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.4 | 6.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 0.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 1.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 3.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 12.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 17.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.3 | 0.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.3 | 4.5 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.3 | 3.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 3.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 2.8 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 4.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 3.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 1.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 11.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 2.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 1.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 1.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 0.7 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 11.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 6.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.2 | 4.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 1.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 1.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 1.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 2.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 0.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 5.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.2 | 3.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 0.4 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 4.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 18.9 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 10.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 4.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 3.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 1.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 1.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 0.2 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.2 | 2.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 1.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 6.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.6 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 2.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 3.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 2.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 1.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 1.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 0.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 2.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 5.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 3.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 2.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 1.4 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |